• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马尔尼菲青霉丝状和酵母形式对两性霉素B、氟康唑、5-氟胞嘧啶和伊曲康唑的体外敏感性。

In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.

作者信息

Sekhon A S, Garg A K, Padhye A A, Hamir Z

机构信息

National Centre for Human Mycotic Diseases, University of Alberta, Edmonton, Canada.

出版信息

Eur J Epidemiol. 1993 Sep;9(5):553-8. doi: 10.1007/BF00209535.

DOI:10.1007/BF00209535
PMID:8307142
Abstract

The mycelial (25 degrees C) and yeast-like (37 degrees C) forms of Penicillium marneffei clinical and type strains were investigated for their in vitro susceptibility to amphotericin B (AmB), 5-fluorocytosine (5-FC), fluconazole (FLU) and itraconazole (ITZ), using Bacto antibiotic medium 3, yeast-nitrogen, Sabouraud's dextrose (pH 5.7) and high resolution (pH 7.1) broth media (1ml/tube), respectively. Results indicated that the minimal inhibitory and minimal fungicidal concentrations (MICs and MFCs) for the mycelial cultures of P. marneffei to AmB were in the range 0.78-1.56 and 0.78-3.125 micrograms/ml, respectively, as against 3.125-25 micrograms (MICs) for the yeast form cultures. The MFCs to AmB for the yeast form were one dilution higher. The MICs to FLU were generally lower for the yeast form (6.25-25 micrograms) than the mycelial form (25-50 micrograms/ml), whereas MFCs for the mycelial cultures were > 100 micrograms as compared to 6.25-100 micrograms for their yeast form. The MICs for the mycelial form to 5-FC ranged from < 0.195-0.39 microgram. Higher MICs (6.25 micrograms) were recorded for their yeast form. The MFCs to 5-FC for the yeast form were 25-100 micrograms/ml. The MICs for the mycelial form to ITZ ranged from < 0.195 to 3.125 micrograms/ml. Higher values (< 0.195-50 micrograms) were recorded for their yeast-like form. The MFCs to ITZ for mycelial and yeast forms ranged from < 0.195-0.39 and 25-100 micrograms/ml, respectively. Results indicate that P. marneffei's yeast form is more sensitive to FLU and ITZ (8 of 10 strains) while the mycelial form displayed greater susceptibility to AmB and 5-FC. The MICs for ITZ remained steady in SD medium, pH 5.7 to 7.1. However, some strains gave higher MIC values (0.39-1.56 micrograms/ml) when tested in the HR.

摘要

研究了马尔尼菲青霉临床菌株和标准菌株在25℃时的丝状形式以及在37℃时的酵母样形式对两性霉素B(AmB)、5-氟胞嘧啶(5-FC)、氟康唑(FLU)和伊曲康唑(ITZ)的体外敏感性,分别使用细菌抗生素培养基3、酵母氮源、沙氏葡萄糖(pH 5.7)和高分辨率(pH 7.1)肉汤培养基(1ml/试管)。结果表明,马尔尼菲青霉丝状培养物对AmB的最低抑菌浓度和最低杀菌浓度(MIC和MFC)分别在0.78 - 1.56和0.78 - 3.125微克/毫升范围内,而酵母形式培养物的MIC为3.125 - 25微克。酵母形式对AmB的MFC高一个稀释度。酵母形式对FLU的MIC通常低于丝状形式(6.25 - 25微克),丝状培养物的MFC大于100微克,而酵母形式为6.25 - 100微克。丝状形式对5-FC的MIC范围为<0.195 - 0.39微克。酵母形式的MIC较高(6.25微克)。酵母形式对5-FC的MFC为25 - 100微克/毫升。丝状形式对ITZ的MIC范围为<0.195至3.125微克/毫升。酵母样形式的数值较高(<0.195 - 50微克)。丝状和酵母形式对ITZ的MFC分别为<0.195 - 0.39和25 - 100微克/毫升。结果表明,马尔尼菲青霉的酵母形式对FLU和ITZ更敏感(10株中有8株),而丝状形式对AmB和5-FC更敏感。在pH 5.7至7.1的SD培养基中,ITZ的MIC保持稳定。然而,一些菌株在高分辨率培养基中测试时给出了更高的MIC值(0.39 - 1.56微克/毫升)。

相似文献

1
In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.马尔尼菲青霉丝状和酵母形式对两性霉素B、氟康唑、5-氟胞嘧啶和伊曲康唑的体外敏感性。
Eur J Epidemiol. 1993 Sep;9(5):553-8. doi: 10.1007/BF00209535.
2
In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.柬埔寨马尔尼菲青霉菌株丝状和酵母形式的体外抗真菌药物敏感性
J Clin Microbiol. 2006 Nov;44(11):4208-10. doi: 10.1128/JCM.00902-06. Epub 2006 Sep 13.
3
In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine.新型三唑类药物D0870对马尔尼菲青霉菌的体外抗真菌活性与两性霉素B、氟康唑、伊曲康唑、咪康唑和氟胞嘧啶的比较。
Mycoses. 1996 Nov-Dec;39(11-12):453-6. doi: 10.1111/j.1439-0507.1996.tb00096.x.
4
In vitro susceptibility of Trichosporon beigelii to antifungal agents.白吉利丝孢酵母对抗真菌药物的体外敏感性
J Chemother. 1996 Dec;8(6):445-8. doi: 10.1179/joc.1996.8.6.445.
5
In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.棘白菌素类抗真菌药LY303,366与伊曲康唑和两性霉素B相比对曲霉属真菌的体外活性
Antimicrob Agents Chemother. 1998 Oct;42(10):2726-30. doi: 10.1128/AAC.42.10.2726.
6
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.曲霉菌对传统药物和新型药物的体外药敏及协同研究。
Diagn Microbiol Infect Dis. 1992 Jan;15(1):21-34. doi: 10.1016/0732-8893(92)90053-v.
7
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.在体外对从塞尔维亚患者脑脊液和血液中分离的新型隐球菌的两性霉素 B、5-氟胞嘧啶、氟康唑和伊曲康唑的抗真菌活性。
J Mycol Med. 2012 Sep;22(3):243-8. doi: 10.1016/j.mycmed.2012.06.002. Epub 2012 Aug 10.
8
Effects of culture media on the in vitro susceptibility of selected opportunistic fungi to fluconazole and itraconazole.培养基对所选机会性真菌体外氟康唑和伊曲康唑敏感性的影响。
Chemotherapy. 1992;38(3):169-73. doi: 10.1159/000238958.
9
In vitro sensitivity of medically significant Fusarium species to various antimycotics.具有医学意义的镰刀菌属菌种对多种抗真菌药物的体外敏感性
Chemotherapy. 1994 Jul-Aug;40(4):239-44. doi: 10.1159/000239199.
10
In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.中国东北地区吉林省球孢子菌分离株的体外抗真菌药敏试验:酵母相和菌丝相的比较。
Braz J Microbiol. 2021 Mar;52(1):81-90. doi: 10.1007/s42770-020-00316-y. Epub 2020 Jun 17.

引用本文的文献

1
Clinical features of talaromycosis in people living with HIV/AIDS (PWHA) and patients with anti-interferon-γ autoantibodies.人类免疫缺陷病毒/获得性免疫综合征(HIV/AIDS)感染者及抗干扰素-γ自身抗体患者的足分支菌病临床特征
PLoS Negl Trop Dis. 2025 May 9;19(5):e0012992. doi: 10.1371/journal.pntd.0012992. eCollection 2025 May.
2
Development and validation of a colorimetric antifungal susceptibility testing method for the dimorphic fungus Talaromyces marneffei.显色法测定二相性真菌马尔尼菲篮状菌抗真菌药物敏感性的方法的建立和验证。
Med Mycol. 2023 Nov 6;61(11). doi: 10.1093/mmy/myad111.
3
Comparison of in vitro Susceptibilities of in Mold and Yeast Forms in Malaysia.

本文引用的文献

1
[Penicillium marneffei n.sp., agent of a mycosis of the reticuloendothelial system].[马尔尼菲青霉新种,网状内皮系统真菌病的病原体]
Mycopathol Mycol Appl. 1959 Nov 30;11:327-53. doi: 10.1007/BF02089507.
2
[Penicillosis from Rhizomys sinensis].来自中华竹鼠的青霉病
Bull Soc Pathol Exot Filiales. 1956 May-Jun;49(3):418-21.
3
Disseminated hyalohyphomycosis caused by a novel human pathogen, Fusarium napiforme.由新型人类病原体萝卜镰刀菌引起的播散性透明丝孢霉病。
马来西亚霉菌和酵母形态体外药敏性比较。
Infect Drug Resist. 2023 Mar 22;16:1629-1635. doi: 10.2147/IDR.S398743. eCollection 2023.
4
Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.马尔尼菲青霉病(帚霉病):病原菌发现 60 年后对重大真菌病临床趋势的深入了解。
Mycopathologia. 2019 Dec;184(6):709-720. doi: 10.1007/s11046-019-00410-2.
5
Activity of Posaconazole against Talaromyces marneffei by Broth Microdilution and Etest Methods and Comparison to Itraconazole, Voriconazole, and Anidulafungin.泊沙康唑通过肉汤微量稀释法和Etest法对马尔尼菲篮状菌的活性及其与伊曲康唑、伏立康唑和阿尼芬净的比较
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.01480-16. Print 2017 Mar.
6
Subcutaneous mycoses: an aetiological study of 15 cases in a tertiary care hospital at Dibrugarh, Assam, northeast India.皮下真菌病:印度东北部阿萨姆邦迪布鲁加尔一家三级护理医院的 15 例病因研究。
Mycopathologia. 2015 Jun;179(5-6):425-35. doi: 10.1007/s11046-015-9861-x. Epub 2015 Jan 18.
7
Penicillium marneffei Infection in AIDS.艾滋病患者的马尔尼菲青霉感染
Patholog Res Int. 2011 Feb 10;2011:764293. doi: 10.4061/2011/764293.
8
In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.柬埔寨马尔尼菲青霉菌株丝状和酵母形式的体外抗真菌药物敏感性
J Clin Microbiol. 2006 Nov;44(11):4208-10. doi: 10.1128/JCM.00902-06. Epub 2006 Sep 13.
9
In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms.米卡芬净(FK463)对双相真菌的体外抗真菌活性:酵母样和菌丝体形式的比较。
Antimicrob Agents Chemother. 2003 Apr;47(4):1376-81. doi: 10.1128/AAC.47.4.1376-1381.2003.
10
Penicillium marneffei: types and drug susceptibility.马尔尼菲青霉:类型与药敏性
Mycopathologia. 2001;149(3):109-15. doi: 10.1023/a:1007245226495.
J Clin Microbiol. 1993 Jun;31(6):1461-7. doi: 10.1128/jcm.31.6.1461-1467.1993.
4
Infection caused by Penicillium marneffei: description of first natural infection in man.马尔尼菲青霉菌引起的感染:首例人类自然感染的描述。
Am J Clin Pathol. 1973 Aug;60(2):259-63. doi: 10.1093/ajcp/60.2.259.
5
Effect of culture media on in vitro susceptibility testing of fluconazole against some yeasts.培养基对氟康唑对某些酵母菌体外药敏试验的影响。
Mycoses. 1991 Jul-Aug;34(7-8):319-22. doi: 10.1111/j.1439-0507.1991.tb00668.x.
6
Standardized susceptibility testing of fluconazole: an international collaborative study.氟康唑的标准化药敏试验:一项国际合作研究。
Antimicrob Agents Chemother. 1992 Sep;36(9):1805-9. doi: 10.1128/AAC.36.9.1805.
7
In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.马尔尼菲青霉和隐秘腐霉对多种抗真菌剂的体外敏感性
Eur J Epidemiol. 1992 May;8(3):427-32. doi: 10.1007/BF00158578.
8
In vitro growth inhibitory studies of phacidin against some dermatophytes, opportunistic and systemic fungi, and yeasts pathogenic on man.关于phacidin对一些皮肤癣菌、机会性真菌和系统性真菌以及对人类致病的酵母菌的体外生长抑制研究。
J Antimicrob Chemother. 1977 Jan;3(1):95-100. doi: 10.1093/jac/3.1.95.